NG2 Stock Overview Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. More details
Rewards Risk Analysis No risks detected for NG2 from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Neogen Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Neogen Historical stock prices Current Share Price US$10.20 52 Week High US$16.30 52 Week Low US$10.20 Beta 1.23 1 Month Change -18.40% 3 Month Change -29.17% 1 Year Change -31.54% 3 Year Change -67.31% 5 Year Change -69.32% Change since IPO 378.87%
Recent News & Updates
Neogen Introduces Igenity BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk Jan 21
Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay Jan 16
Neogen Corporation announced delayed 10-Q filing Jan 11
Second quarter 2025 earnings released: US$2.10 loss per share (vs US$0.016 loss in 2Q 2024) Jan 11
Neogen Corporation Appoints David Naemura as Chief Operating Officer Jan 08
Neogen Corporation Appoints Thierry Bernard to Serve on the Governance and Sustainability and Compensation and Talent Management Committees Dec 20 See more updates
Neogen Introduces Igenity BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk Jan 21
Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay Jan 16
Neogen Corporation announced delayed 10-Q filing Jan 11
Second quarter 2025 earnings released: US$2.10 loss per share (vs US$0.016 loss in 2Q 2024) Jan 11
Neogen Corporation Appoints David Naemura as Chief Operating Officer Jan 08
Neogen Corporation Appoints Thierry Bernard to Serve on the Governance and Sustainability and Compensation and Talent Management Committees Dec 20
Neogen Corporation to Report Q2, 2025 Results on Jan 09, 2025 Dec 19
Neogen Corporation Launches Petetrifilm Bacillus Cereus Count Plate to Enhance Food Safety Testing Efficiency Dec 18
First quarter 2025 earnings released: US$0.06 loss per share (vs US$0.007 profit in 1Q 2024) Oct 10 Neogen Corporation Announces That Douglas E. Jones Communicated His Intent to Retire in Early 2025
Neogen Appoints Thierry Bernard as Director, Effective November 1, 2024 Oct 01
Neogen Corporation to Report Q1, 2025 Results on Oct 10, 2024 Sep 19
Neogen Corporation, Annual General Meeting, Oct 24, 2024 Sep 16
Neogen Corporation Provides Earnings Guidance for the Year 2025 Aug 01
Full year 2024 earnings released: US$0.044 loss per share (vs US$0.12 loss in FY 2023) Jul 31
Neogen Corporation to Report Q4, 2024 Results on Jul 30, 2024 Jul 12
New minor risk - Share price stability Jun 06
Neogen® Launches New Molecular Method for Detection of Two Salmonella Serotypes Apr 30
Neogen®? Farm Fluid Max Disinfectant Launches Across Great Britain Livestock & Poultry Markets Apr 12
President recently bought €264k worth of stock Apr 11 Neogen Corporation Updates Earnings Guidance for the Full Year 2024 Apr 09
Neogen Corporation Announces Board Changes Apr 05
Neogen Corporation to Report Q3, 2024 Results on Apr 09, 2024 Mar 20
Neogen® Releases Surekill® Gel Bait Pro Applicator Jan 18
Second quarter 2024 earnings released: US$0.016 loss per share (vs US$0.19 loss in 2Q 2023) Jan 10
Neogen Corporation Provides Earnings Guidance for the Fiscal Year 2024 Jan 09
Neogen Corporation to Report Q2, 2024 Results on Jan 09, 2024 Dec 20
Neogen®? Launches Highly Sensitive Quantitative Elisa Assay for the Detection of Walnut Allergens Nov 30
Neogen Corporation Provides Revenue Guidance for the Fiscal Year 2024 Oct 11
Neogen Corporation to Report Q1, 2024 Results on Oct 10, 2023 Sep 27
Neogen Corporation, Annual General Meeting, Oct 25, 2023 Sep 19
Neogen® Launches Igenity® Enhanced Dairy Aug 17
Neogen Corporation Unveils over 100 New Genetic Tests Aug 09 Neogen Corporation announced delayed annual 10-K filing Aug 01
Full year 2023 earnings released: US$0.12 loss per share (vs US$0.45 profit in FY 2022) Jul 28
Neogen Corporation to Report Q4, 2023 Results on Jul 27, 2023 Jul 12
Neogen Corporation Launches DNA Test for Beef-on-Dairy Cattlec Jun 07 Neogen Corporation Launches New Assays for Histamine Detection
Neogen Corporation Launches New Assays for Natural Toxin Detection May 10
Third quarter 2023 earnings released: EPS: US$0.038 (vs US$0.05 in 3Q 2022) Mar 31
Second quarter 2023 earnings released: US$0.19 loss per share (vs US$0.10 profit in 2Q 2022) Jan 07
Neogen Corporation to Report Q2, 2023 Results on Jan 05, 2023 Dec 23 Neogen Corporation Launches Synergize Disinfectant in Europe, the Middle East, Africa
Neogen Corporation Launches Ready-To-Use Chemiluminescent Substrate Nov 01
Investor sentiment improved over the past week Oct 29
Association of Official Analytical Chemists Approves Neogen Corporation's Megazyme Rapid Integrated Total Dietary Fiber Assay as the Standard Method Oct 26
VP & CFO recently bought €60k worth of stock Oct 13
Neogen Corporation Adds Companion™ Ready-To-Use Disinfectant to Biosecurity Portfolio Oct 11
Neogen Corporation Launches New Genomic Management Technology Sep 30
First quarter 2023 earnings released: EPS: US$0.048 (vs US$0.16 in 1Q 2022) Sep 29
President recently bought €328k worth of stock Sep 29
Neogen Corporation Announces Executive Changes Sep 28
Neogen Corporation Launches Quantitative Cashew ELISA Assay Sep 20
Neogen Corporation Appoint Board of Directors Sep 10
Neogen Corporation (NasdaqGS:NEOG) completed the acquisition of Food Safety Business from 3M Company (NYSE:MMM). Sep 02
Neogen Corporation, Annual General Meeting, Oct 06, 2022 Aug 31
President recently bought €396k worth of stock Aug 03
Full year 2022 earnings released: EPS: US$0.45 (vs US$0.57 in FY 2021) Jul 28
Neogen Corporation (NasdaqGS:NEOG) acquired Thai-Neo Biotech Co., Ltd. Jul 07
Neogen(R) Corporation Announces Viroxide Super(Tm) Approval for Canadian Distribution Jun 07
Neogen Corporation Launches Prozap® Gamma-Defense Insect Control Solution Jun 02
Neogen Corporation Launches Enhanced Quantitative Peanut Elisa Assay May 19
Neogen Announces Executive Changes Apr 22
Neogen Corporation Launches Prozap Protectus Pour-On Insecticide Apr 12
Neogen Corporation Adds Synergize Ready-To-Use Disinfectant to Biosecurity Portfolio Mar 03
Neogen Corporation Launches K-Blue Luminescent Substrate Feb 02
Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Dec 23
Neogen Corporation (NasdaqGS:NEOG) entered into a definitive agreement to acquire Food Safety Business from 3M Company (NYSE:MMM) for approximately $1 billion. Dec 16
Neogen Corporation (NasdaqGS:NEOG) acquired Genetic Veterinary Sciences, Inc. Dec 10
Neogen Corporation (NasdaqGS:NEOG) acquired Delf (Uk) Limited. Dec 02
First quarter 2022 earnings released: EPS US$0.16 (vs US$0.15 in 1Q 2021) Sep 22
Neogen Corporation (NasdaqGS:NEOG) acquired Cap Innovet, Inc. Sep 21
Full year 2021 earnings released: EPS US$0.57 (vs US$0.57 in FY 2020) Jul 21
AOAC Approves NEOGEN Soleris® Direct Yeast and Mold for Use in Cannabis Jun 18
Neogen Corporation Announces That the U.S. EPA Has Granted an Expedited, Initial Registration for Neogen to Distribute Neogen® Viroxide Super™ Disinfectant in the U.S Jun 03
NEOGEN Launches Improved Sanitation Monitoring System May 04
Insider recently sold €77k worth of stock Apr 16
Third quarter 2021 earnings released: EPS US$0.25 (vs US$0.23 in 3Q 2020) Mar 25
Neogen Corporation Announces Retirement of G. Bruce Papesh as Board of Director Mar 04
Neogen launches wastewater detection screening for COVID-19 Feb 16
Insider recently sold €160k worth of stock Feb 10
Neogen Corporation Relaunches FDA-Approved ThyroKare™ Tablets for Dogs Feb 02
New 90-day high: €71.50 Jan 27
Neogen Corporation Launches Reveal® Q+ for Aflatoxin M1 Jan 13
New 90-day high: €68.50 Jan 07
Neogen Corporation (NasdaqGS:NEOG) acquired Megazyme u.c. Jan 06
Revenue misses expectations Dec 31
Second quarter 2021 earnings released: EPS US$0.30 Dec 24
Revenue misses expectations Dec 24
Neogen Corporation Launches Quick, Easy Tests for Meat Speciation Dec 15
Insider recently sold €549k worth of stock Nov 20
Neogen Launches Igenity® Feeder, A New Commercial DNA Sorting Tool Oct 29
Neogen Corporation Launches Reveal® 3-D Food Extraction Buffer Oct 16 Shareholder Returns NG2 DE Medical Equipment DE Market 7D -6.4% 3.6% 0.5% 1Y -31.5% -0.9% 15.3%
See full shareholder returns
Return vs Market: NG2 underperformed the German Market which returned 13.7% over the past year.
Price Volatility Is NG2's price volatile compared to industry and market? NG2 volatility NG2 Average Weekly Movement 6.5% Medical Equipment Industry Average Movement 6.4% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: NG2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: NG2's weekly volatility (7%) has been stable over the past year.
About the Company Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.
Show more Neogen Corporation Fundamentals Summary How do Neogen's earnings and revenue compare to its market cap? NG2 fundamental statistics Market cap €2.24b Earnings (TTM ) -€461.18m Revenue (TTM ) €884.77m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) NG2 income statement (TTM ) Revenue US$913.83m Cost of Revenue US$465.21m Gross Profit US$448.62m Other Expenses US$924.95m Earnings -US$476.33m
Last Reported Earnings
Nov 30, 2024
Earnings per share (EPS) -2.20 Gross Margin 49.09% Net Profit Margin -52.12% Debt/Equity Ratio 33.4%
How did NG2 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/07 23:47 End of Day Share Price 2025/02/07 00:00 Earnings 2024/11/30 Annual Earnings 2024/05/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Neogen Corporation is covered by 18 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution David Westenberg CL King & Associates, Inc. Steven Crowley Craig-Hallum Capital Group LLC Paul Knight Credit Agricole Securities (USA) Inc.
Show 15 more analysts 
